Literature DB >> 17947524

West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein.

Antje Hoenen1, Wenjun Liu, Georg Kochs, Alexander A Khromykh, Jason M Mackenzie.   

Abstract

The human MxA protein is a type I and III interferon (IFN)-induced protein with proven antiviral activity against RNA viruses. In this study, we investigated the effect of MxA expression on the replication of West Nile Virus strain Kunjin (WNV(KUN)). Pretreatment of A549 cells with IFN-alpha lead to increased expression of MxA, which contributed to inhibition of WNV(KUN) replication and secretion. However, in Vero cells stably expressing the MxA protein, WNV(KUN) replication, maturation and secretion was not inhibited. Biochemical and subcellular localization studies of WNV(KUN) proteins and MxA suggest that the MxA activity was not compromised by a flavivirus-encoded antagonist. Instead, we show that characteristic membranous structures induced during WNV(KUN) replication provide partial protection from MxA, possibly by 'hiding' WNV(KUN) replication components. This distinct compartmentalization of viral replication and components of the cellular antiviral response may be an evolutionary mechanism by which flaviviruses can hide from host surveillance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947524     DOI: 10.1099/vir.0.83125-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  30 in total

1.  The endoplasmic reticulum provides the membrane platform for biogenesis of the flavivirus replication complex.

Authors:  Leah K Gillespie; Antje Hoenen; Gary Morgan; Jason M Mackenzie
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 2.  The innate immune playbook for restricting West Nile virus infection.

Authors:  Kendra M Quicke; Mehul S Suthar
Journal:  Viruses       Date:  2013-10-30       Impact factor: 5.048

Review 3.  West Nile virus: A re-emerging pathogen revisited.

Authors:  Miguel A Martín-Acebes; Juan-Carlos Saiz
Journal:  World J Virol       Date:  2012-04-12

Review 4.  Innate host responses to West Nile virus: Implications for central nervous system immunopathology.

Authors:  Giada Rossini; Maria Paola Landini; Francesco Gelsomino; Vittorio Sambri; Stefania Varani
Journal:  World J Virol       Date:  2013-05-12

5.  TRIM79α, an interferon-stimulated gene product, restricts tick-borne encephalitis virus replication by degrading the viral RNA polymerase.

Authors:  R Travis Taylor; Kirk J Lubick; Shelly J Robertson; James P Broughton; Marshall E Bloom; Wade A Bresnahan; Sonja M Best
Journal:  Cell Host Microbe       Date:  2011-09-15       Impact factor: 21.023

6.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

7.  Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles.

Authors:  Anna K Overby; Vsevolod L Popov; Matthias Niedrig; Friedemann Weber
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

8.  The essential, nonredundant roles of RIG-I and MDA5 in detecting and controlling West Nile virus infection.

Authors:  John S Errett; Mehul S Suthar; Aimee McMillan; Michael S Diamond; Michael Gale
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

9.  Three-dimensional architecture of tick-borne encephalitis virus replication sites and trafficking of the replicated RNA.

Authors:  Lisa Miorin; Inés Romero-Brey; Paolo Maiuri; Simone Hoppe; Jacomine Krijnse-Locker; Ralf Bartenschlager; Alessandro Marcello
Journal:  J Virol       Date:  2013-04-03       Impact factor: 5.103

Review 10.  Regulation of flavivirus RNA synthesis and capping.

Authors:  Bejan J Saeedi; Brian J Geiss
Journal:  Wiley Interdiscip Rev RNA       Date:  2013-08-08       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.